Abstract
This report examines the global portable ultrasound market, which is poised for significant growth driven by increasing demand for point-of-care diagnostics and the rising prevalence of chronic diseases. The analysis covers key segments, including the high-growth transducers and probes category and the leading trauma and emergency care application. While hospitals and surgical centers remain the primary end users, the Asia Pacific region is expected to experience the fastest expansion. Technological advancements in AI and wireless connectivity further bolster market opportunities.
Related Questions
USD 2.49 billion in 2025; USD 3.84 billion by 2030
9.0% CAGR (forecast period: 2025-2030)
Philips Healthcare, GE Healthcare, Canon Medical Systems Corporation, Siemens Healthineers, FUJIFILM Corporation, Hologic Inc., Samsung Electronics Co., Ltd., Esaote SpA, Chison Medical Technologies Co., Ltd., MobiSante Inc., Clarius, MedGyn Products, Inc., Promed Technology, Neusoft Corporation
increasing prevalence of chronic diseases, growing demand for point-of-care diagnostics, technological advancements
Summary
Market Overview
The global portable ultrasound market is projected to grow from USD 2.49 billion in 2025 to USD 3.84 billion by 2030, expanding at a CAGR of 9.0% during the forecast period.
Market Drivers and Trends
- Point-of-Care Diagnostics: Increasing demand for point-of-care diagnostics is driving the need for portable ultrasound technology, particularly through non-invasive imaging methods across various settings.
- Disease Prevalence: The growing prevalence of chronic and lifestyle-related diseases necessitates prompt imaging solutions in clinical environments.
- Technological Advancements: Improvements in technology have enhanced imaging quality, increasing the appeal of these devices to hospitals, clinics, and remote healthcare providers.
- Clinical Applications: A greater emphasis on maternal health and increasing evidence supporting portable ultrasound use in emergency and intensive care settings are contributing to market growth.
- Virtual Healthcare: The continued exploration of virtual healthcare solutions is expected to drive significant interest in telemedicine and home-based care.
Market Segmentation
By Product
- Transducers/Probes: This segment is expected to register the highest growth rate during the forecast period and currently comprises the largest portion of the market due to its essential role in image acquisition.
- Specialization: Each transducer is designed for specific anatomy and depth, including linear transducers (superficial anatomy), curvilinear transducers (deeper organs), and phased array transducers (cardiac applications).
- System Requirements: A single portable ultrasound system typically requires multiple unique probes to achieve full diagnostic capability.
- Economic Factors: Transducers are highly engineered devices utilizing sophisticated piezoelectric components and advanced materials, leading to high per-unit costs.
- Replacement Cycle: High susceptibility to wear and tear from heavy use and the necessity for sterilization leads to frequent replacements, solidifying their dominant market presence.
By Application
- Trauma & Emergency Care: This segment commanded the largest market share in 2024.
- Critical Need: Demand is driven by the requirement for rapid, real-time diagnostic imaging in time-sensitive situations, such as emergency rooms, ambulances, or disaster sites.
- Capabilities: Devices allow for immediate assessment of internal injuries, bleeding, or organ damage without requiring patient transport.
- Operational Efficiency: Compact size, ease of use, and quick boot-up times facilitate fast decision-making in high-pressure environments.
- Standardization: The adoption of protocols like FAST (Focused Assessment with Sonography in Trauma) further drives usage.
- Global Expansion: Expanding emergency services in developing regions and remote areas continue to reinforce this segment's leading share.
By End User
- Hospitals & Surgical Centers: This segment held the largest share of the market in 2024.
- Usage Drivers: High patient volumes, diverse diagnostic needs, and perioperative infrastructure drive adoption.
- Clinical Settings: Used for point-of-care diagnostics, emergency situations, pre- and post-operative evaluations, and bedside imaging in intensive care units (ICUs) and operating rooms.
- Patient Care: The ability to perform rapid, non-invasive scans without moving critically ill patients is a key value proposition.
- Routine Workflows: Adoption is enhanced by use in cardiology, obstetrics, and musculoskeletal imaging.
By Region
- Asia Pacific: Expected to register the highest growth rate (CAGR) during the forecast period.
- Infrastructure Growth: Expanding healthcare infrastructure in China, India, and Southeast Asia facilitates technology adoption.
- Demographics: An aging population and the rising prevalence of chronic diseases increase demand for accessible diagnostic tools.
- Affordability: Portable ultrasound devices are significantly more cost-effective than CT, MRI, or traditional ultrasound systems.
- Innovation: Advancements in artificial intelligence and wireless technology are improving device functionality and appeal.
- Other Regions: North America, Europe, Latin America, and the Middle East & Africa.
Competitive Landscape
Prominent Players
- Philips Healthcare (Netherlands)
- GE Healthcare (US)
- Canon Medical Systems Corporation (Japan)
- Siemens Healthineers (Germany)
- FUJIFILM Corporation (Japan)
- Hologic Inc. (US)
- Samsung Electronics Co., Ltd. (South Korea)
- Esaote SpA (Italy)
- Chison Medical Technologies Co., Ltd. (China)
- MobiSante Inc. (US)
- Clarius (Canada)
- MedGyn Products, Inc. (US)
- Promed Technology (China)
- Neusoft Corporation (China)
Participant Breakdown
- By Company Type: Tier 1 (40%), Tier 2 (30%), Tier 3 (30%)
- By Designation: C-level Executives (55%), Directors (27%), Others (18%)
- By Region: North America (35%), Europe (32%), Asia Pacific (25%), Latin America (6%), Middle East & Africa (2%)
Research Coverage & Strategic Insights
The report provides a comprehensive analysis of the portable ultrasound market, segmented by product, platform, application, end user, and region. It includes micro-level analysis of trends, growth opportunities, and revenue potential across five major regions.
Market Dynamics
- Key Drivers: Increasing prevalence of chronic diseases, growing demand for point-of-care diagnostics, technological advancements, and rising public/private investments, funding, and grants.
- Restraints: Unfavorable reimbursement landscapes and high operating costs.
- Opportunities: Integration of AI in portable ultrasound, high growth in emerging markets, and the development of wearable and wireless ultrasound devices.
- Challenges: Limited battery life, device durability concerns, and a shortage of qualified sonographers.
Areas of Analysis
- Product Development/Innovation: Emerging technologies, R&D activities, and recent product and service launches.
- Market Growth: In-depth geographical insights.
- Market Diversification: Analysis of new products, unexplored geographies, latest trends, and investments.
- Competitive Assessment: Detailed evaluation of market shares, product offerings, and leading strategies of key players.
Key Benefits of the Report
- For New Entrants: Provides essential information for understanding investment opportunities.
- Risk Analysis: Offers insights into both key and smaller players to assist in investment decision-making.
- Strategic Decision-Making: Supports strategy through detailed analysis of trends, challenges, drivers, and opportunities, with accurate segmentation by end user and region.
Table of Contents
1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.3 MARKET SCOPE 26
1.3.1 PORTABLE ULTRASOUND MARKET SEGMENTATION
1.3.2 INCLUSIONS AND EXCLUSIONS 27
1.4 YEARS CONSIDERED 27
1.5 CURRENCY CONSIDERED 28
1.6 STAKEHOLDERS 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
2.1.1 SECONDARY RESEARCH 31
- 2.1.1.1 Key data from secondary sources 32
2.1.2 PRIMARY RESEARCH 33
- 2.1.2.1 Key industry insights 34
2.2 MARKET SIZE ESTIMATION APPROACH 35
2.3 MARKET FORECASTING APPROACH 40
2.4 DATA TRIANGULATION AND MARKET BREAKDOWN 41
2.5 MARKET SHARE ASSESSMENT 42
2.6 RESEARCH ASSUMPTIONS 42
2.7 RESEARCH LIMITATIONS 42
2.8 RISK ASSESSMENT 43
3 EXECUTIVE SUMMARY 44
4 PREMIUM INSIGHTS 47
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN THE PORTABLE ULTRASOUND MARKET 47
4.2 NORTH AMERICA: PORTABLE ULTRASOUND MARKET
4.3 GEOGRAPHIC SNAPSHOT OF PORTABLE ULTRASOUND MARKET 49
5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
5.2 MARKET DYNAMICS 50
5.2.1 DRIVERS 51
- 5.2.1.1 Increasing prevalence of chronic diseases 51
- 5.2.1.2 Growing demand for point-of-care diagnostics 52
- 5.2.1.3 Rising technological advancements in portable ultrasound devices 52
- 5.2.1.4 Growing public and private investments, funding, and grants 54
5.2.2 RESTRAINTS 54
- 5.2.2.1 Unfavorable reimbursements 54
5.2.3 OPPORTUNITIES 55
- 5.2.3.1 Integration of AI in portable ultrasound 55
- 5.2.3.2 High growth potential in emerging economies 55
- 5.2.3.3 Development of wearable and wireless ultrasound devices 56
5.2.4 CHALLENGES 57
- 5.2.4.1 Limited battery life and device durability 57
- 5.2.4.2 Shortage of skilled sonographers 57
5.3 VALUE CHAIN ANALYSIS 58
5.4 SUPPLY CHAIN ANALYSIS 59
5.4.1 PROMINENT COMPANIES 59
5.4.2 SMALL AND MEDIUM-SIZED ENTERPRISES 60
5.4.3 MARKETING & SALES, DISTRIBUTION, AND POST-SALES SERVICES 60
5.4.4 END USERS 60
5.5 PORTER’S FIVE FORCES ANALYSIS 61
5.5.1 THREAT OF NEW ENTRANTS 62
5.5.2 BARGAINING POWER OF SUPPLIERS 62
5.5.3 BARGAINING POWER OF BUYERS 62
5.5.4 THREAT OF SUBSTITUTES 62
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 62
5.6 KEY STAKEHOLDERS AND BUYING CRITERIA 63
5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS 63
5.6.2 BUYING CRITERIA 64
5.7 PATENT ANALYSIS 65
5.8 TRADE DATA ANALYSIS 67
5.8.1 IMPORT DATA 67
5.8.2 EXPORT DATA 68
5.9 KEY CONFERENCES AND EVENTS, 2025-2026 69
5.10 UNMET NEEDS AND KEY PAIN POINTS 70
5.11 ECOSYSTEM ANALYSIS 70
5.12 IMPACT OF 2025 US TARIFFS 71
5.12.1 INTRODUCTION 71
5.12.2 KEY TARIFF RATES 72
5.12.3 PRICE IMPACT ANALYSIS 73
5.12.4 IMPACT ON COUNTRY/REGION 73
- 5.12.4.1 US 73
- 5.12.4.2 Europe 73
- 5.12.4.3 Asia Pacific 74
- 5.12.4.4 Impact on end-user facilities 74
5.13 IMPACT OF GEN AI ON PORTABLE ULTRASOUND MARKET 75
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 76
5.15 TECHNOLOGY ANALYSIS 77
5.15.1 KEY TECHNOLOGIES 77
- 5.15.1.1 Probes 77
- 5.15.1.2 Contrast-enhanced portable ultrasound 78
- 5.15.1.3 Portable and handheld ultrasound devices 78
5.15.2 COMPLEMENTARY TECHNOLOGIES 78
- 5.15.2.1 Elastography 78
- 5.15.2.2 Transrectal Ultrasound 78
- 5.15.2.3 Transvaginal Ultrasound 79
5.15.3 ADJACENT TECHNOLOGIES 79
- 5.15.3.1 Positron emission tomography and computed tomography 79
5.16 CASE STUDY ANALYSIS 79
5.16.1 EFFICIENT POWER FOR HANDHELD ULTRASOUND UNITS 79
5.16.2 ADVANCEMENTS IN USING PORTABLE ULTRASOUND WITH ARTIFICIAL INTELLIGENCE IN PRE-HOSPITAL EMERGENCIES AND DISASTER RESPONSE SETTINGS 80
5.16.3 EFFECTIVENESS OF HANDHELD PORTABLE ULTRASOUND IN RURAL HOSPITAL IN GUATEMALA 80
5.17 REGULATORY LANDSCAPE 81
5.17.1 NORTH AMERICA 81
- 5.17.1.1 US 81
- 5.17.1.2 Canada 82
5.17.2 EUROPE 82
5.17.3 ASIA PACIFIC 83
- 5.17.3.1 Japan 83
- 5.17.3.2 China 84
- 5.17.3.3 India 85
5.17.4 REGULATORY BODIES, GOVERNMENT AGENCIES
5.18 INVESTMENT AND FUNDING SCENARIO 88
5.19 PRICING ANALYSIS 89
5.19.1 AVERAGE SELLING PRICE TREND, BY REGION 90
5.19.2 AVERAGE SELLING PRICE OF HANDHELD ULTRASOUND
5.20 REIMBURSEMENT SCENARIO 94
6 PORTABLE ULTRASOUND MARKET, BY PRODUCT TYPE 95
6.1 INTRODUCTION 96
6.2 TRANSDUCERS/PROBES 96
6.2.1 CURVILINEAR/CONVEX ARRAY 97
- 6.2.1.1 Allows for wide-field imaging and better visualization of structures at depth 97
6.2.2 LINEAR ARRAY 98
- 6.2.2.1 Versatile tool in ultrasound imaging 98
6.2.3 PHASED ARRAY 99
- 6.2.3.1 Ability to steer and focus the portable ultrasound beam electronically to drive growth 99
6.2.4 OTHER ARRAY TYPES 100
6.3 SYSTEMS & CONSOLES 101
6.3.1 ADVANCED IMAGING CAPABILITIES AND ROBUST PERFORMANCE
6.4 ACCESSORIES 102
6.4.1 CRITICAL TO ENSURING IMAGE QUALITY, USER CONVENIENCE
6.5 SOFTWARE & SERVICES 103
6.5.1 ADVANCED FEATURES LIKE REAL-TIME IMAGE GUIDANCE, CLOUD-BASED IMAGE STORAGE AND SHARING, AND AUTOMATED DIAGNOSTICS TO DRIVE GROWTH 103
7 PORTABLE ULTRASOUND MARKET, BY PLATFORM 104
7.1 INTRODUCTION 105
7.2 TROLLEY/CART BASED 105
7.2.1 INCREASED USE IN ACUTE CARE SETTINGS AND EMERGENCY CARE IN HOSPITALS TO DRIVE GROWTH 105
7.3 HANDHELD 106
7.3.1 INCREASING NUMBER OF TRAUMA/EMERGENCY CASES TO DRIVE DEMAND 106
7.4 LAPTOP BASED 107
7.4.1 ABILITY TO DELIVER NEAR-CART-LEVEL PERFORMANCE IN A COMPACT FORM TO DRIVE GROWTH 107
7.5 TABLET BASED 108
7.5.1 LIGHTWEIGHT AND USER-FRIENDLY DESIGN TO DRIVE DEMAND 108
8 PORTABLE ULTRASOUND MARKET, BY END USER 110
8.1 INTRODUCTION 111
8.2 HOSPITALS & SURGICAL CENTERS 112
8.2.1 INCREASING NUMBER OF CANCER CASES TO DRIVE DEMAND 112
8.3 IMAGING CENTERS 113
8.3.1 NEED FOR STREAMLINED WORKFLOWS AND POINT-OF-CARE DIAGNOSTICS TO DRIVE GROWTH 113
8.4 AMBULATORY CARE CENTERS 114
8.4.1 INCREASING DEMAND FOR COMPACT PORTABLE ULTRASOUND DEVICES TO DRIVE GROWTH 114
8.5 OTHER END USERS 115
9 PORTABLE ULTRASOUND MARKET, BY APPLICATION 116
9.1 INTRODUCTION 117
9.2 OBSTETRICS/GYNECOLOGY 117
9.2.1 ADOPTION OF AI IN PORTABLE ULTRASOUND TO DRIVE SEGMENTAL GROWTH 117
9.3 OTHER APPLICATIONS 119
9.4 CARDIOLOGY 119
9.4.1 RISING PREVALENCE OF CARDIAC DISEASES TO DRIVE DEMAND 119
9.4.2 ORTHOPEDIC AND MUSCULOSKELETAL 120
- 9.4.2.1 Rising prevalence of osteoarthritis to drive growth 120
9.5 VASCULAR 121
9.5.1 NEED FOR EARLY DETECTION OF VASCULAR DISEASES TO DRIVE GROWTH 121
9.6 PEDIATRIC 122
9.6.1 LEVERAGING PEDIATRIC PORTABLE ULTRASOUND TO COMBAT NEONATAL MORTALITY 122
9.7 UROLOGY 123
9.7.1 PORTABLE ULTRASOUND WIDELY USED IN DIAGNOSIS AND TREATMENT OF VARIOUS UROLOGICAL DISORDERS 123
9.7.2 PAIN MANAGEMENT 124
- 9.7.2.1 Increasing adoption of portable ultrasound in outpatient settings to drive growth 124
10 PORTABLE ULTRASOUND MARKET, BY REGION 126
10.1 INTRODUCTION 127
10.2 NORTH AMERICA 128
10.2.1 MACROECONOMIC OUTLOOK 128
10.2.2 US 132
- 10.2.2.1 Presence of advanced healthcare infrastructure to drive market 132
10.2.3 CANADA 136
- 10.2.3.1 New product launch & conference events to drive market 136
10.3 EUROPE 139
10.3.1 MACROECONOMIC OUTLOOK 139
10.3.2 GERMANY 142
- 10.3.2.1 Rapid expansion in applications of portable ultrasound technologies to drive market 142
10.3.3 UK 145
- 10.3.3.1 Increase in awareness about different diagnostic imaging procedures to drive market 145
10.3.4 FRANCE 148
- 10.3.4.1 Increasing demand for portable ultrasound devices for routine health check-ups, prenatal care, and diagnostic procedures to drive market 148
10.3.5 ITALY 151
- 10.3.5.1 Increased availability of reimbursement coverage for diagnostic procedures to drive market 151
10.3.6 SPAIN 154
- 10.3.6.1 Growing adoption of point-of-care portable ultrasound to drive market 154
10.3.7 REST OF EUROPE 158
10.4 ASIA PACIFIC 161
10.4.1 MACROECONOMIC OUTLOOK 161
10.4.2 CHINA 165
- 10.4.2.1 Emphasis on modernization and expansion of rural healthcare infrastructure to drive market 165
10.4.3 JAPAN 168
- 10.4.3.1 Established healthcare infrastructure and research facilities to drive market 168
10.4.4 INDIA 172
- 10.4.4.1 Rising adoption of advanced diagnostic imaging technologies to drive market 172
10.4.5 AUSTRALIA 175
- 10.4.5.1 Increasing investments in healthcare infrastructure to drive market 175
10.4.6 SOUTH KOREA 178
- 10.4.6.1 Rising investments in disease diagnostic system development to drive market 178
10.4.7 REST OF ASIA PACIFIC 181
10.5 LATIN AMERICA 184
10.5.1 MACROECONOMIC OUTLOOK 184
10.5.2 BRAZIL 187
- 10.5.2.1 Growing adoption of healthcare insurance to drive market 187
10.5.3 MEXICO 191
- 10.5.3.1 Investment in portable ultrasound devices to drive market 191
10.5.4 REST OF LATIN AMERICA 193
10.6 MIDDLE EAST & AFRICA 196
10.6.1 MACROECONOMIC OUTLOOK 197
10.6.2 GCC COUNTRIES 200
- 10.6.2.1 Government initiatives aimed at digital health and telemedicine to drive market 200
10.6.3 REST OF MIDDLE EAST & AFRICA 203
11 COMPETITIVE LANDSCAPE 207
11.1 INTRODUCTION 207
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 207
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PORTABLE ULTRASOUND MARKET 208
11.3 REVENUE ANALYSIS, 2021-2024 210
11.4 MARKET SHARE ANALYSIS, 2024 211
11.4.1 RANKING OF KEY MARKET PLAYERS 212
11.5 COMPANY EVALUATION MATRIX: PORTABLE ULTRASOUND MARKET, 2024 213
11.5.1 STARS 213
11.5.2 EMERGING LEADERS 213
11.5.3 PERVASIVE PLAYERS 213
11.5.4 PARTICIPANTS 213
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 215
- 11.5.5.1 Company footprint 215
- 11.5.5.2 Product type footprint 216
- 11.5.5.3 Platform footprint 217
- 11.5.5.4 Application footprint 218
- 11.5.5.5 End user footprint 219
- 11.5.5.6 Region footprint 220
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES (2024) 221
11.6.1 PROGRESSIVE COMPANIES 221
11.6.2 RESPONSIVE COMPANIES 221
11.6.3 DYNAMIC COMPANIES 221
11.6.4 STARTING BLOCKS 221
11.7 COMPANY VALUATION AND FINANCIAL METRICS 224
11.7.1 FINANCIAL METRICS 224
11.7.2 COMPANY VALUATION 225
11.8 BRAND/PRODUCT COMPARISON 225
11.9 COMPETITIVE SCENARIO 226
11.9.1 PRODUCT LAUNCHES & APPROVALS 226
11.9.2 DEALS 227
12 COMPANY PROFILES 228
12.1 KEY PLAYERS 228
12.1.1 GE HEALTHCARE 228
- 12.1.1.1 Business overview 228
- 12.1.1.2 Products offered 229
- 12.1.1.3 Recent developments 230
- 12.1.1.3.1 Product launches 230
- 12.1.1.3.2 Deals 231
- 12.1.1.3.3 Other developments 232
- 12.1.1.4 MnM view 232
- 12.1.1.4.1 Right to win 232
- 12.1.1.4.2 Strategic choices 232
- 12.1.1.4.3 Weaknesses & competitive threats 233
12.1.2 PHILIPS HEALTHCARE 234
- 12.1.2.1 Business overview 234
- 12.1.2.2 Products offered 235
- 12.1.2.3 Recent developments 237
- 12.1.2.3.1 Product launches 237
- 12.1.2.3.2 Deals 237
- 12.1.2.4 MnM view 238
- 12.1.2.4.1 Right to win 238
- 12.1.2.4.2 Strategic choices 238
- 12.1.2.4.3 Weaknesses & competitive threats 238
12.1.3 CANON MEDICAL SYSTEMS CORPORATION 239
- 12.1.3.1 Business overview 239
- 12.1.3.2 Products offered 241
- 12.1.3.3 Recent developments 242
- 12.1.3.3.1 Product launches 242
- 12.1.3.3.2 Deals 242
- 12.1.3.3.3 Expansions 243
- 12.1.3.4 MnM view 243
- 12.1.3.4.1 Right to win 243
- 12.1.3.4.2 Strategic choices 243
- 12.1.3.4.3 Weaknesses & competitive threats 243
12.1.4 SIEMENS HEALTHINEERS AG 244
- 12.1.4.1 Business overview 244
- 12.1.4.2 Products offered 246
- 12.1.4.3 Recent developments 246
- 12.1.4.3.1 Product launches 246
- 12.1.4.3.2 Deals 247
- 12.1.4.3.3 Expansions 247
- 12.1.4.4 MnM view 248
- 12.1.4.4.1 Right to win 248
- 12.1.4.4.2 Strategic choices 248
- 12.1.4.4.3 Weaknesses & competitive threats 248
12.1.5 FUJIFILM CORPORATION 249
- 12.1.5.1 Business overview 249
- 12.1.5.2 Products offered 250
- 12.1.5.3 Recent developments 251
- 12.1.5.3.1 Product launches 251
- 12.1.5.3.2 Deals 251
- 12.1.5.3.3 Expansions 252
- 12.1.5.4 MnM view 252
- 12.1.5.4.1 Right to win 252
- 12.1.5.4.2 Strategic choices 252
- 12.1.5.4.3 Weaknesses & competitive threats 252
12.1.6 HOLOGIC, INC 253
- 12.1.6.1 Business overview 253
- 12.1.6.2 Products offered 254
- 12.1.6.3 Recent developments 255
- 12.1.6.3.1 Product launches 255
- 12.1.6.3.2 Deals 255
- 12.1.6.3.3 Expansions 256
12.1.7 SAMSUNG ELECTRONICS CO., LTD 257
- 12.1.7.1 Business overview 257
- 12.1.7.2 Products offered 258
- 12.1.7.3 Recent developments 261
- 12.1.7.3.1 Product launches 261
- 12.1.7.3.2 Deals 261
- 12.1.7.3.3 Other developments 262
12.1.8 MINDRAY MEDICAL INTERNATIONAL LIMITED 263
- 12.1.8.1 Business overview 263
- 12.1.8.2 Products offered 264
- 12.1.8.3 Recent developments 266
- 12.1.8.3.1 Product launches 266
- 12.1.8.3.2 Deals 267
12.1.9 ESAOTE SPA 268
- 12.1.9.1 Business overview 268
- 12.1.9.2 Products offered 268
- 12.1.9.3 Recent developments 270
- 12.1.9.3.1 Product launches 270
- 12.1.9.3.2 Other developments 271
12.1.10 CHISON MEDICAL TECHNOLOGIES CO., LTD 272
- 12.1.10.1 Business overview 272
- 12.1.10.2 Products offered 272
- 12.1.10.3 Recent developments 273
- 12.1.10.3.1 Product launches 273
- 12.1.10.3.2 Deals 273
12.1.11 NEUSOFT CORPORATION 274
- 12.1.11.1 Business overview 274
- 12.1.11.2 Products offered 275
- 12.1.11.3 Recent developments 275
- 12.1.11.3.1 Product launches 275
12.1.12 KONICA MINOLTA, INC 276
- 12.1.12.1 Business overview 276
- 12.1.12.2 Products offered 277
- 12.1.12.3 Recent developments 277
- 12.1.12.3.1 Product launches 277
- 12.1.12.3.2 Deals 277
12.1.13 CLARIUS 278
- 12.1.13.1 Business overview 278
- 12.1.13.2 Products offered 278
- 12.1.13.3 Recent developments 279
- 12.1.13.3.1 Product launches and approvals 279
- 12.1.13.3.2 Deals 281
12.1.14 MEDGYN PRODUCTS, INC 282
- 12.1.14.1 Business overview 282
- 12.1.14.1.1 Products offered 282
- 12.1.14.1 Business overview 282
12.1.15 PROMED TECHNOLOGY CO., LTD 283
- 12.1.15.1 Business overview 283
- 12.1.15.2 Products offered 283
12.2 OTHER COMPANIES 285
12.2.1 WHITE EAGLE SONIC TECHNOLOGIES, INC 285
12.2.2 PERLONG MEDICAL EQUIPMENT CO., LTD 286
12.2.3 YOUKEY MEDICAL 287
12.2.4 SIUI 287
12.2.5 TELEMED, MEDICAL IMAGING EQUIPMENT DESIGN & MANUFACTURING 289
12.2.6 BUTTERFLY NETWORK, INC 290
12.2.7 ALPINION MEDICAL SYSTEMS 291
12.2.8 EDAN INSTRUMENTS, INC 292
12.2.9 SHENZHEN LANDWIND INDUSTRY CO., LTD 293
12.2.10 ECHONOUS INC 294
12.2.11 MOBISANTE 295
12.2.12 SHENZHEN WISONIC MEDICAL TECHNOLOGY CO., LTD 296
12.2.13 SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT CO., LTD 297
12.2.14 SONOSCAPE MEDICAL CORP 297
12.2.15 CURA HEALTHCARE 299
13 APPENDIX 300
13.1 DISCUSSION GUIDE 300
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 304
13.3 CUSTOMIZATION OPTIONS 306
13.4 RELATED REPORTS 306
13.5 AUTHOR DETAILS 307